FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely clinical biochemistry, and can be used for a comprehensive assessment of the amount of oxidatively modified proteins in biological fluids. The optical density of a pre-prepared sample is measured in the wavelength range of 230-535 nm, and a graph of the dependence of the optical density of the sample under study on the wavelength is plotted. The graph is divided into segments according to the wavelength ranges of absorption fractions: aldehyde dinitrophenylhydrazones of the main (ADNPHm) and neutral (ADNPHn) character and ketone-dinitrophenyl-hydrazones of the main (KDNPHm) and neutral (KDNPHn) character: ADNPHn in the range of 230-367 nm; ADNPHm - 258-264 and 428-520 nm; KDNPHn - 363-367 nm; KDNPHm - 430-434 and 524-535 nm. In each segment, when calculating the areas of optical density for each of the fractions: SADNPHn, SADNPHm, SKDNPHn and SKDNPHm, a numerical integration method is used - the Simpson formula: S= h/3[(y0+4(y1+y3+…+yn-1) + 2(y2+y4+…+yn-2)+yn)], where: S is the area of the optical density of one of the fractions of the sample: SADNPHn, SADNPHm, SKDNPHn, SKDNPHm, y0, y1, y2, y3, y4, yn-2, yn-1, yn are the optical density indicators, h is the step of the optical density interval. The total number of oxidatively modified proteins is calculated by summing the areas of the fractions of SADNPHn, SADNPHm, SKDNPHn and SKDNPHm.
EFFECT: method provides an opportunity to increase the accuracy of a comprehensive assessment of the content of oxidatively modified proteins in biological fluids during spectrophotometric analysis by applying a calculation method using the numerical integration method: the Simpson formula, which makes it possible to calculate the results of the study in more detail.
1 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMPLEX ASSESSMENT OF PRODUCT CONTENT OF OXIDATIVE MODIFICATION OF PROTEINS IN TISSUES AND BIOLOGICAL FLUIDS | 2013 |
|
RU2524667C1 |
METHOD FOR ESTIMATION OF COW MILK PROTEIN OXIDATIVE MODIFICATION INDICATORS | 2016 |
|
RU2623145C1 |
METHOD OF PREDICTING FREQUENT EXACERBATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2808485C1 |
METHOD FOR DETERMINING OXIDATIVE PROTEIN MODIFICATION IN SUBSTANCE POOL OF AVERAGE MOLECULAR WEIGHT IN BLOOD SERUM, PLASMA, ERYTHROCYTE, AND IN URINE | 2012 |
|
RU2525437C1 |
METHOD FOR DETERMINING THE CONCENTRATION OF CARBONYLATED PROTEINS WITHOUT PRELIMINARY DEPOSITION | 2021 |
|
RU2782440C1 |
METHOD FOR THE DETERMINATION OF OXIDATIVELY MODIFIED PROTEINS IN BIOLOGICAL FLUIDS | 2021 |
|
RU2754434C1 |
METHOD OF DETERMINING OXIDATIVE MODIFICATION OF FIBRINOGEN IN BLOOD PLASMA BY CONTENT OF CARBONYL GROUPS IN FIBRINOUS CLOT | 2014 |
|
RU2595806C2 |
METHOD FOR PREDICTION OF DEVELOPING ALLERGIC DISEASES IN INFANTS | 2009 |
|
RU2424528C2 |
METHOD FOR DETERMINING A PROLONGED RATE OF DEATH | 2018 |
|
RU2687077C1 |
IMPROVED ANTIBODIES BINDING Aβ-PROTOFIBRILS | 2015 |
|
RU2700104C2 |
Authors
Dates
2022-04-18—Published
2021-06-11—Filed